Sensitive and selective detection of Mucin1 in pancreatic cancer using hybridization chain reaction with the assistance of Fe3O4@polydopamine nanocomposites
-
Published:2022-02-23
Issue:1
Volume:20
Page:
-
ISSN:1477-3155
-
Container-title:Journal of Nanobiotechnology
-
language:en
-
Short-container-title:J Nanobiotechnol
Author:
Dong Qing,Jia Xiuna,Wang Yuling,Wang Hao,Liu Qiong,Li Dan,Wang Jin,Wang Erkang
Abstract
AbstractPancreatic cancer is characterized as the worst for diagnosis lacking symptoms at the early stage, which results in a low overall survival rate. The frequently used techniques for pancreatic cancer diagnosis rely on imaging and biopsy, which have limitations in requiring experienced personnel to operate the expensive instruments and analyze the results. Therefore, there is a high demand to develop alternative tools or methods to detect pancreatic cancer. Herein, we propose a new strategy to enhance the detection sensitivity of pancreatic cancer cells both in biofluids and on tissues by combining the unique property of dopamine coated Fe3O4 nanoparticles (Fe3O4@DOP NPs) to specifically quench and separate free 6-carboxyfluorescein (FAM) labeled DNA (H1-FAM/H2-FAM), and the key feature of hybridization chain reaction (HCR) amplification. We have determined the limit of detection (LOD) to be 21 ~ 41 cells/mL for three different pancreatic cancer cell lines. It was also discovered that the fluorescence intensity of pancreatic cancer cells was significantly higher than that of HPDE-C7 and HepG-2 cells (control cell lines), which express lower MUC1 protein. Moreover, the HCR amplification system was used to identify the cancer cells on pancreatic tissue, which indicated the versatility of our strategy in clinical application. Therefore, the presented detection strategy shows good sensitivity, specificity and has great potential for the diagnosis of pancreatic cancer.
Graphical Abstract
Funder
MOST China Ministerial Standing Committee on Scientific and Technological Cooperation of the Organization of Islamic Cooperation Innovative Research Group Project of the National Natural Science Foundation of China the National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Subject
Pharmaceutical Science,Applied Microbiology and Biotechnology,Biomedical Engineering,Molecular Medicine,Medicine (miscellaneous),Bioengineering
Reference45 articles.
1. Yamamoto K, Venida A, Yano J, Biancur DE, Kakiuchi M, Gupta S, Sohn ASW, Mukhopadhyay S, Lin ELY, Parker SJ, Banh RS, Paulo JA, Wen KW, Debnath J, Kim GE, Mancias JD, Fearon DT, Perera RM, Kimmelman AC. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. Nature. 2020;581:100–5. 2. Hu X, Xia F, Lee J, Li F, Lu X, Zhuo X, Nie G, Ling D. Tailor-made nanomaterials for diagnosis and therapy of pancreatic ductal adenocarcinoma. Adv Sci. 2021;8:2002545. 3. Poruk K, Gay D, Brown K, Mulvihill J, Boucher K, Scaife C, Firpo MA, Mulvihill SJ. The clinical utility of CA 19–9 in pancreatic adenocarcinoma: diagnostic and prognostic updates. Curr Mol Med. 2013;13:340–51. 4. Li YY, Fang QQ, Miao XX, Zhang XY, Zhao Y, Yan J, Zhang YQ, Wu RF, Nie BQ, Hirtz M, Liu J. Aptamer conformation cooperated enzyme-assisted sers (access) enabling ultrasensitive detection of cell surface protein biomarkers in blood samples. ACS sens. 2019;4:2605–14. 5. Meng XD, Yang F, Dong HF, Dou L, Zhang XJ. Recent advances in optical imaging of biomarkers in vivo. Nano Today. 2021;38:101156.
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|